Brimonidine Tartrate/timolol Maleate Solution/ Drops
Product Images NDC 68462-281

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate/timolol Maleate (NDC 68462-281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label-5ml (Bottle Label 5ml)

Bottle-label-5ml (Bottle Label 5ml)
Label for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%, sterile solution for eye use only. Contains 5 mL per bottle. Manufactured by Glenmark Pharmaceuticals Inc., USA. Includes storage instructions and barcode.*
FDA Label Image

Carton-label-5ml (Carton Label 5ml)

Carton-label-5ml (Carton Label 5ml)
Packaging label for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%, 5 mL, sterile eye drops. The label shows the active ingredients, preservative, inactive ingredients, storage instructions, and usual dosage information. Manufactured by SamChunDang Pharm. Co., Ltd. and labeled for Glenmark Pharmaceuticals Inc., USA.*
FDA Label Image

Logo.jpg (Image 02)

FDA Label Image

Brimonidine Tartrate Chemical Structure (Image 1)

Brimonidine Tartrate Chemical Structure (Image 1)
Chemical structure diagram showing the molecular structures of Brimonidine Tartrate and Timolol Maleate, the active ingredients in Brimonidine Tartrate/Timolol Maleate ophthalmic solution.*
FDA Label Image

Timolol Maleate Chemical Structure (Image 2)

Timolol Maleate Chemical Structure (Image 2)
Chemical structure of the active ingredients Brimonidine Tartrate and Timolol Maleate, showing the molecular arrangement of atoms in both compounds used in the ophthalmic solution product by Glenmark Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.